We are thrilled to be starting off 2024 by welcoming our very first UK-based organisation to our Partner Program, Vasantis!
This partnership will focus on supporting patients with specific health conditions alongside Pharma companies with drugs and programs in the same therapy areas, all with the aim of improving outcomes.
In collaboration with the UK’s NHS, patients will be able to use Clinitouch to remain under the care of their clinical team, no matter the location. They will use our technology to input their symptoms and vital sign readings such as blood pressure and oxygen saturation, which will be fed back to their healthcare professionals.
Dedicated pathways which have been co-designed with Pharma will include the ability to not only track medication adherence and effectiveness, but provide patient educational materials to boost confidence, knowledge, and better management of their condition.
Vasantis will work with Pharma to identify opportunities with Integrated Care Boards (ICBs) across the NHS and provide Pharma with the chance to fund the Clinitouch service. Each project is initially expected to support hundreds of patients per ICB, helping to optimise patient outcomes and nurture the Pharma-clinician relationship.
This partnership will initially focus on patients with COPD - specifically those who are highly symptomatic and at high risk of being admitted to hospital. By shifting to a proactive care model that moves hospital-level care to the home, it helps the NHS to free up bed capacity, while allowing people to be cared for from the comfort of their own surroundings.
Ian Welburn, CEO and Founder of Vasantis, said:
"We are delighted to be working in partnership with the Clinitouch team, and by using the collective experience of Vasantis in healthcare, digital health solutions, and the Pharma Industry, combined with the proven success of Clinitouch, we will make a significant positive impact on patient health outcomes."
Chris Barker, CEO & Co-Founder of Clinitouch, added: “This partnership is a great example of how we can leverage health tech to enhance pharmaceutical support for patients. The collaboration between Pharma and digital health holds huge potential, supporting patients in the NHS, in clinical trials and beyond.”
Our first partner of 2024 follows closely behind our recent announcement in December, which aims to provide more accessible healthcare to the community in Bengaluru, India. We’re currently designing digital health projects across five continents – with many more partners to be announced soon. Watch this space…
If you'd like to work with us or hear more about what it's like to be on the Clinitouch Partner Program, visit our webpage today.
We are thrilled to be starting off 2024 by welcoming our very first UK-based organisation to our Partner Program, Vasantis!
This partnership will focus on supporting patients with specific health conditions alongside Pharma companies with drugs and programs in the same therapy areas, all with the aim of improving outcomes.
In collaboration with the UK’s NHS, patients will be able to use Clinitouch to remain under the care of their clinical team, no matter the location. They will use our technology to input their symptoms and vital sign readings such as blood pressure and oxygen saturation, which will be fed back to their healthcare professionals.
Dedicated pathways which have been co-designed with Pharma will include the ability to not only track medication adherence and effectiveness, but provide patient educational materials to boost confidence, knowledge, and better management of their condition.
Vasantis will work with Pharma to identify opportunities with Integrated Care Boards (ICBs) across the NHS and provide Pharma with the chance to fund the Clinitouch service. Each project is initially expected to support hundreds of patients per ICB, helping to optimise patient outcomes and nurture the Pharma-clinician relationship.
This partnership will initially focus on patients with COPD - specifically those who are highly symptomatic and at high risk of being admitted to hospital. By shifting to a proactive care model that moves hospital-level care to the home, it helps the NHS to free up bed capacity, while allowing people to be cared for from the comfort of their own surroundings.
Ian Welburn, CEO and Founder of Vasantis, said:
"We are delighted to be working in partnership with the Clinitouch team, and by using the collective experience of Vasantis in healthcare, digital health solutions, and the Pharma Industry, combined with the proven success of Clinitouch, we will make a significant positive impact on patient health outcomes."
Chris Barker, CEO & Co-Founder of Clinitouch, added: “This partnership is a great example of how we can leverage health tech to enhance pharmaceutical support for patients. The collaboration between Pharma and digital health holds huge potential, supporting patients in the NHS, in clinical trials and beyond.”
Our first partner of 2024 follows closely behind our recent announcement in December, which aims to provide more accessible healthcare to the community in Bengaluru, India. We’re currently designing digital health projects across five continents – with many more partners to be announced soon. Watch this space…
If you'd like to work with us or hear more about what it's like to be on the Clinitouch Partner Program, visit our webpage today.
Shaping the future of healthcare by making it easy and accessible for everyone, no matter their location.
